Ledyard National Bank’s United Therapeutics UTHR Stock Holding History

Ledyard National Bank’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Sell	2,745 -75	-3%	-$42.2K	0.12%	108
2026 Q1	$1.67M	Hold	2,820	–	–	0.15%	93
2025 Q4	$1.37M	Buy	+2,820	New	+$1.31M	0.12%	102
2019 Q1	–	Sell	-50	Closed	-$5K	–	615
2018 Q4	$5K	Hold	50	–	–	﹤0.01%	669
2018 Q3	$6K	Hold	50	–	–	﹤0.01%	645
2018 Q2	$6K	Hold	50	–	–	﹤0.01%	652
2018 Q1	$6K	Hold	50	–	–	﹤0.01%	689
2017 Q4	$7K	Hold	50	–	–	﹤0.01%	698
2017 Q3	$6K	Buy	+50	New	+$6.38K	﹤0.01%	709

Other funds holding UTHR

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Ledyard National Bank's UTHR Position: Q2 2026 in Review

Ledyard National Bank reduced its United Therapeutics (UTHR) stake by 2.7% in Q2 2026, selling an estimated $42.2K and leaving 2,745 shares worth $1.49M. The position accounts for 0.12% of the portfolio, ranked #108.

Ledyard National Bank first reported a position in UTHR in Q3 2017 and has held it in 9 quarters since. The position peaked at $1.67M in Q1 2026. 281 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Ledyard National Bank held 2,745 shares of United Therapeutics worth $1.49M as of Q2 2026.
Ledyard National Bank sold 75 United Therapeutics shares in Q2 2026, an estimated $42.2K.
United Therapeutics made up 0.12% of Ledyard National Bank's portfolio in Q2 2026, its #108 holding.
Ledyard National Bank first reported a position in United Therapeutics in Q3 2017 and has held it in 9 quarters since.
Ledyard National Bank's United Therapeutics position peaked at $1.67M in Q1 2026.
281 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.